Cloderm (clocortolone pivalate) cream, 0.1% is a topical mid potent steroid product indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
As per the terms of the agreement, Valeant Pharma is eligible to receive an upfront payment and future royalties from Promius Pharma as the consideration for the right to manufacture, distribute and market Cloderm cream in the US, effective immediately.
Promius Pharma head and Proprietary Products senior vice president Raghav Chari said Cloderm cream is a time-tested product and has strong recognition among dermatologists.